Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

July 22, 2010 – Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have ...

Home July 22, 2010
Home
News

July 13, 2010 – AstraZeneca recently announced that the U.S. District Court has found that the substance patent ...

Home July 13, 2010
Home
News

July 1, 2010 – Two medical companies say they will work with physicians to further investigate ways to manage ...

Home July 01, 2010
Home
News

July 1, 2010 – The U.S. Food and Drug Administration (FDA) recently added a warning to the information on ...

Home July 01, 2010
Home
News

June 24, 2010 – The first cohort of patients was fully enrolled this week in a clinical study of a new drug meant ...

Home June 24, 2010
Home
News

June 14, 2010 - High levels of high-density lipoprotein (HDL) — known as good cholesterol — can not only make a ...

Home June 14, 2010
Home
News

June 8, 2010 – New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation ...

Home June 08, 2010
Home
Technology

June 2, 2010 – A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was ...

Home June 02, 2010
Home
News

May 4, 2010 – A deal has been struck to produce a generic version of Merck & Company’s Zetia (ezetimibe). In the ...

Home May 04, 2010
Home
News

April 27, 2010 – A popular statin gained a new indication today in the European Union for prevention of major ...

Home April 27, 2010
Home
News

April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial ...

Home April 26, 2010
Home
Technology

April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol ...

Home April 18, 2010
Home
News

April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce ...

Home April 08, 2010
Home
Technology

March 30, 2010 – The FDA granted tentative approval for Teva Pharmaceutical’s abbreviated new drug application ...

Home March 30, 2010
Home
Feature

March 18, 2010 – The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood ...

Home March 23, 2010
Home
Subscribe Now